OTLK CIK: 1649989

Outlook Therapeutics, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−54.3
FY22:
−56.7
FY23:
−43.0
FY24:
−68.8
FY25:
−51.8
Change from FY21 to FY25
millions USD
FY21:
56.2
FY22:
59.6
FY23:
49.0
FY24:
60.3
FY25:
45.0
millions USD
FY21:
1.94
FY22:
2.92
FY23:
6.00
FY24:
−8.46
FY25:
−6.84

All amounts in millions USD Data source:SEC EDGAR